Krystal Biotech, Inc. (KRYS) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 116.36M | 107.11M | 97.8M | 96.04M | 88.18M | 91.14M | 83.84M | 70.28M | 45.25M | 42.14M | 8.56M | 0 |
| Revenue Growth % | 31.95% | 17.52% | 16.65% | 36.65% | 94.88% | 116.26% | 879.91% | - | - | - | - | - |
| Cost of Goods Sold | 6.32M | 10.92M | 5.66M | 7.17M | 5.03M | 4.95M | 6.68M | 6.01M | 2.42M | 4.38M | 223K | 0 |
| COGS % of Revenue | 5.43% | 10.19% | 5.79% | 7.46% | 5.7% | 5.43% | 7.97% | 8.55% | 5.35% | 10.39% | 2.61% | - |
| Gross Profit | 110.03M | 96.19M | 92.14M | 88.88M | 83.16M | 86.19M | 77.16M | 64.28M | 42.83M | 37.77M | 8.33M | 0 |
| Gross Margin % | 94.57% | 89.81% | 94.21% | 92.54% | 94.3% | 94.57% | 92.03% | 91.45% | 94.65% | 89.61% | 97.39% | - |
| Gross Profit Growth % | 32.32% | 11.6% | 19.41% | 38.28% | 94.15% | 128.23% | 825.92% | - | - | - | - | - |
| Operating Expenses | 56.34M | 51.75M | 50.76M | 49.57M | 46.98M | 44.81M | 54.72M | 55.71M | 49.52M | 34.63M | 34.33M | 38.05M |
| OpEx % of Revenue | 48.42% | 48.32% | 51.9% | 51.61% | 53.27% | 49.17% | 65.27% | 79.26% | 109.43% | 82.17% | 401.19% | - |
| Selling, General & Admin | 41.01M | 41.28M | 37.58M | 35.16M | 32.72M | 31.29M | 28.71M | 27.63M | 26.06M | 23.26M | 23.7M | 25.9M |
| SG&A % of Revenue | 35.25% | 38.54% | 38.42% | 36.61% | 37.11% | 34.33% | 34.25% | 39.31% | 57.59% | 55.19% | 276.96% | - |
| Research & Development | 15.33M | 16.2M | 13.19M | 14.41M | 14.26M | 13.52M | 13.51M | 15.58M | 10.96M | 11.37M | 10.63M | 12.14M |
| R&D % of Revenue | 13.18% | 15.12% | 13.48% | 15% | 16.17% | 14.84% | 16.11% | 22.17% | 24.21% | 26.98% | 124.23% | - |
| Other Operating Expenses | 0 | -1000K | 0 | 0 | 0 | 0 | 1000K | 1000K | 1000K | 0 | 0 | 0 |
| Operating Income | 53.69M | 44.44M | 41.37M | 39.31M | 36.18M | 41.38M | 22.43M | 8.57M | -6.68M | 3.14M | -25.99M | -38.05M |
| Operating Margin % | 46.14% | 41.49% | 42.3% | 40.93% | 41.02% | 45.4% | 26.76% | 12.19% | -14.77% | 7.45% | -303.8% | - |
| Operating Income Growth % | 48.41% | 7.39% | 84.43% | 358.87% | 641.25% | 1218.64% | 186.3% | 122.51% | 86.31% | 109.02% | 17.35% | -32.33% |
| EBITDA | 55.41M | 46.2M | 42.98M | 40.85M | 37.81M | 42.93M | 23.96M | 10.59M | -5.08M | 4.64M | -24.63M | -36.57M |
| EBITDA Margin % | 47.63% | 43.14% | 43.95% | 42.53% | 42.88% | 47.11% | 28.58% | 15.06% | -11.22% | 11.02% | -287.84% | - |
| EBITDA Growth % | 46.56% | 7.61% | 79.38% | 285.85% | 845.04% | 824.31% | 197.3% | 128.95% | 89.32% | 113.79% | 19.19% | -31.66% |
| D&A (Non-Cash Add-back) | 1.73M | 1.76M | 1.61M | 1.54M | 1.63M | 1.55M | 1.53M | 2.02M | 1.61M | 1.51M | 1.36M | 1.48M |
| EBIT | 53.69M | 37.84M | 47.97M | 39.31M | 36.18M | 41.38M | 34.93M | 21.07M | 5.82M | 10.66M | -25.99M | -38.05M |
| Net Interest Income | 0 | -14.06M | 6.59M | 7.47M | 0 | 0 | 0 | 7.48M | 7.62M | 7.52M | 6.74M | 4.84M |
| Interest Income | 0 | -14.06M | 6.59M | 7.47M | 0 | 0 | 0 | 7.48M | 7.62M | 7.52M | 6.74M | 4.84M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 7.75M | 6.7M | 6.59M | 7.47M | 7.42M | 7.23M | 7.34M | 7.48M | 7.62M | 7.52M | 106.74M | 4.84M |
| Pretax Income | 61.44M | 51.13M | 47.97M | 46.77M | 43.6M | 48.61M | 29.77M | 16.05M | 932K | 10.66M | 80.75M | -33.21M |
| Pretax Margin % | 52.8% | 47.74% | 49.05% | 48.7% | 49.44% | 53.34% | 35.51% | 22.83% | 2.06% | 25.29% | 943.75% | - |
| Income Tax | 5.51M | -268K | -31.4M | 8.44M | 7.86M | 3.13M | 2.59M | 477K | 0 | 1.97M | 0 | 0 |
| Effective Tax Rate % | 8.97% | -0.52% | -65.46% | 18.05% | 18.04% | 6.44% | 8.7% | 2.97% | 0% | 18.44% | 0% | 0% |
| Net Income | 55.93M | 51.4M | 79.36M | 38.33M | 35.73M | 45.48M | 27.18M | 15.57M | 932K | 8.69M | 80.75M | -33.21M |
| Net Margin % | 48.07% | 47.99% | 81.15% | 39.91% | 40.52% | 49.9% | 32.42% | 22.15% | 2.06% | 20.63% | 943.75% | - |
| Net Income Growth % | 56.53% | 13.02% | 192% | 146.23% | 3734.01% | 423.23% | -66.34% | 146.88% | 102.06% | 127.12% | 370.51% | -18.15% |
| Net Income (Continuing) | 55.93M | 51.4M | 79.36M | 38.33M | 35.73M | 45.48M | 27.18M | 15.57M | 932K | 8.69M | 80.75M | -33.21M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 1.83 | 1.70 | 2.66 | 1.29 | 1.20 | 1.52 | 0.91 | 0.53 | 0.03 | 0.30 | 2.79 | -1.25 |
| EPS Growth % | 52.5% | 11.84% | 192.31% | 143.4% | 3900% | 406.67% | -67.38% | 142.4% | 101.7% | 124% | 338.46% | -13.64% |
| EPS (Basic) | 1.91 | 1.77 | 2.74 | 1.33 | 1.24 | 1.58 | 0.95 | 0.54 | 0.03 | 0.31 | 2.88 | -1.25 |
| Diluted Shares Outstanding | 30.51M | 29.95M | 29.83M | 29.75M | 29.87M | 29.88M | 29.9M | 29.64M | 29.29M | 28.82M | 28.89M | 26.66M |
| Basic Shares Outstanding | 29.29M | 28.94M | 28.95M | 28.91M | 28.82M | 28.75M | 28.72M | 28.6M | 28.3M | 28.17M | 28.04M | 26.66M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |